AMPY vs NCSM

The company exhibits severe financial distress based on a Piotroski F-Score of 2/9, indicating weak financial health. Despite a low Price/Book of 0.49 and a forward P/E below sector average, persistent negative earnings surprises, declining revenue, and negative profit margin undermine valuation appeal. Operating margin and gross margin appear healthy but are inconsistent with overall profitability, which remains negative. The lack of Altman Z-Score and intrinsic value metrics, combined with deteriorating earnings trends and bearish technicals, suggests high risk.

NCSM presents a paradoxical profile: it is fundamentally undervalued with a Graham Number of $98.24 and a low P/E of 8.03, yet it carries a weak Piotroski F-Score of 3/9, indicating deteriorating financial health trends. While the balance sheet is exceptionally clean with a Debt/Equity ratio of 0.09 and high liquidity, the sharp increase in Forward P/E (24.21) suggests a significant expected contraction in earnings. Explosive recent earnings growth is offset by bearish insider sentiment and a very weak technical trend (10/100). The stock is a value play with high volatility and concerning momentum signals.